Vaccine: X, published by Elsevier, is a premier open access journal dedicated to advancing research in the interdisciplinary fields of immunology and microbiology, infectious diseases, molecular medicine, and public health. With an ISSN of 2590-1362 and operating since 2019, the journal has rapidly established an influential role, achieving Q2 rankings in major categories such as Immunology and Microbiology, Infectious Diseases, and Public Health for 2023. Its commitment to disseminating cutting-edge research is evident from its broad scope, focusing on innovative vaccines and therapies that are critical for global health. Researchers and professionals will find value in the accessible nature of the journal, which has been recognized for its contributions to veterinary medicine as well, with a Q1 ranking in the miscellaneous veterinary category. The journal proudly showcases high-quality, peer-reviewed articles and welcomes submissions that push the boundaries of current knowledge, making it an essential resource for anyone involved in vaccine research and development.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

Osong Public Health and Research Perspectives is an esteemed open-access journal dedicated to advancing knowledge in the fields of Public Health and Infectious Diseases. Published by the Korea Disease Control & Prevention Agency, this journal serves as a vital resource for researchers, professionals, and students alike, addressing significant health challenges and disseminating research findings that contribute to public health advancements worldwide. Recognized for its impact, the journal boasts a Q2 ranking in both Infectious Diseases and Public Health, Environmental and Occupational Health categories, as well as a prestigious 94th percentile in Scopus rankings, underscoring its influence and quality. Since its inception in 2010, Osong Public Health and Research Perspectives has provided open access to critical research, ensuring that vital information is readily available to enhance public health initiatives and policy-making. With a commitment to upholding high academic standards, this journal continues to be a cornerstone for collaborative research and discourse within the global health community.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

Journal of Public Health in Africa (ISSN: 2038-9922, E-ISSN: 2038-9930) is a premier open-access journal published by PAGEPRESS PUBL, dedicated to advancing the field of public health within the African context. Established in 2010, this journal provides a platform for researchers, practitioners, and policymakers to disseminate original research, reviews, and case studies that contribute to the understanding of public health challenges and advancements in Africa. With its increasing visibility, the journal is positioned in the Q4 quartile in the categories of Public Health, Environmental and Occupational Health and currently ranks #474 out of 577 in its field according to Scopus metrics. The open access model ensures that vital research is freely accessible to a global audience, thus enhancing knowledge sharing and collaboration. Since coverage of the journal has been discontinued in Scopus after previous years, authors are encouraged to contribute innovative findings which address pressing health issues, ultimately striving to improve health outcomes across the continent. The journal is based in Italy and invites submissions from diverse disciplines to promote a multidisciplinary approach to public health.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

JOURNAL OF TRAVEL MEDICINE, published by Oxford University Press Inc, is a preeminent scholarly journal dedicated to the field of travel medicine. With an impressive impact factor and a remarkable ranking in the Q1 category across multiple disciplines including Infectious Diseases, Public Health, and Environmental and Occupational Health, this journal is pivotal for researchers, healthcare professionals, and students interested in the complexities of health risks associated with global travel. It has maintained its rigorous academic standards since its inception in 1994, continuing to serve as a vital resource and platform for disseminating innovative research, case studies, and reviews that address emerging challenges in travel health. With a strong commitment to advancing public health knowledge, the JOURNAL OF TRAVEL MEDICINE fosters dialogue and collaboration among the global research community and contributes significantly to evidence-based practices in the field. For those interested in cutting-edge findings and developments, this journal remains an essential source of information and guidance.

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

JOURNAL OF PUBLIC HEALTH is a prestigious and influential academic journal dedicated to advancing the field of public health through rigorous research and comprehensive reviews. Published by the esteemed OXFORD UNIVERSITY PRESS in the United Kingdom, this journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Public Health, Environmental and Occupational Health categories, reflecting its significant impact within the academic community. With its established history from 1980 to 2024, the journal also ranks #83 out of 665 in the Scopus categorization for Public Health, positioning it within the top 13% of its field. Although it does not currently operate under an Open Access model, JOURNAL OF PUBLIC HEALTH remains a vital resource for professionals and researchers alike seeking to contribute to discussions and developments that shape health policy and practice globally. The journal's dedication to publishing original research articles, reviews, and case studies makes it an essential platform for both emerging and established scholars aiming to address contemporary public health challenges.